NewsRoom Articles - Page 1110 of 1256

TuesdayMay 09, 2017 3:23 pm

ChineseInvestors.com, Inc. (CIIX) Aims to Excel in CBD Markets

For nearly two decades, ChineseInvestors.com (OTCQB: CIIX) has delivered a wide range of products, information, and services, including several subscription-based services, for the global Chinese speaking population. The specialized investment services company provides real-time market commentary, analysis, and education-related information in the Chinese language, as well as offering consultation, advertising, and public relations services. The company’s product diversity is a result of its growth-focused, long term quest for value-add opportunities. Not satisfied with a 100,000+ user base, a recognizable 18-year-old brand, and a target market in excess of two billion Chinese speaking people, ChineseInvestors.com recently executed a first-to-market milestone by…

TuesdayMay 09, 2017 1:37 pm

Kootenay Zinc Corp. (CSE: ZNK) (OTCQB: KTNNF) Mining for a Mother Lode of Zinc

Zinc prices increased around 60 percent last year to become one of the very best performing metals in 2016. Both Goldman Sachs and The World Bank project higher prices for zinc in 2017 and 2018 because of increased demand and serious global production deficits. Zinc has become the fourth most widely consumed base metal in the world, after iron, aluminum, and copper, partly due to its strong anticorrosive properties. Zinc bonds exceptionally well with other metals, and approximately 60 percent of all zinc produced is used in coating (galvanizing) iron or steel to help prevent rust and corrosion, significantly prolonging the…

TuesdayMay 09, 2017 8:52 am

Navidea Biopharmaceuticals (NYSE: NAVB) Precision Immunodiagnostics, a Game Changer for Patients and Physicians

Precision medicine and precision diagnostics in particular play a major role in today’s medical world, by helping patients and physicians detect various diseases in time, which in turn allows for the proper treatments and care to be prescribed. Companies such as Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) are at the forefront of precision medicine, developing innovative immunodiagnostics and immunotherapeutic platforms that can make a real difference for patients suffering from serious ailments such as cancer or infectious, autoimmune or inflammatory diseases. A leader in precision medicine via the development and commercialization of precision diagnostics and therapeutics based on immune system…

MondayMay 08, 2017 2:55 pm

ABcann Medicinals (TSXV: ABCN) Has Strong Start with Canadian TSX Venture Exchange Listing

Going public appears to be paying off for ABcann Medicals (TSXV: ABCN), since the medical cannabis grower launched its initial public offering (IPO) on the TSX Venture Exchange. Although the IPO was just launched on May 4 (http://nnw.fm/Lt5DO), its value took off, soaring over 26% on the first day and trading over 25% of the total volume on the exchange. ABcann is one of Canada’s major legal cannabis producers, and the public offers are set to provide even more investor benefits as the recreational marijuana market is now positioned for nationwide legalization. Raising capital was part of the company’s decision…

MondayMay 08, 2017 12:55 pm

India Globalization Capital, Inc. (NYSE: IGC) Positioned to Lead in Phytocannabinoid Pharmaceuticals

A study recently highlighted by the American Epilepsy Society (AES) at its 70th annual meeting focused on the potential of cannabidiol (CBD), a derivative of the cannabis plant, as a promising treatment for reducing both the frequency and severity of seizures in children with drug resistant epilepsies (http://nnw.fm/u3xAh). According to the study, patients who received CBD treatment exhibited over 45 percent mean reduction in seizures, and researchers were outspoken in support of further research. Cannabidiol is the most abundant non-psychoactive cannabinoid found in the cannabis plant. Both anecdotal evidence and pre-clinical research have suggested that CBD may have a broad…

MondayMay 08, 2017 8:53 am

Medical Transcription Billing, Corp. (NASDAQ: MTBC) Set to Increase Revenues Substantially in 2017 with New Acquisition

The hiatus after its initial public offering (IPO) in 2014 has come to an end, and Medical Transcription Billing, Corp. (NASDAQ: MTBC; MTBCP) has rebooted its acquisition strategy by bringing two new businesses under its wing. In late 2016, the company completed its acquisition of MediGain, LLC, a Texas-based medical billing specialist, and its subsidiary, Millennium Practice Management Associates, LLC, a New Jersey-based medical billing company. Now, with its bottom line enhanced as costs are spread over the larger organizational structure, MTBC is also set to see its top line improve substantially. The MediGain acquisition will expand MTBC’s revenue base…

FridayMay 05, 2017 3:41 pm

Net Element, Inc. (NASDAQ: NETE) Sees Global Growth Intensify in Processing of Non-Cash Transactions

Net Element, Inc. (NASDAQ: NETE) is growing its sales in the quick-expanding world of cashless transaction processing, which is exhibiting its greatest gains in retail and in the emerging Asian and Latin American markets, according to the World Payments Report 2016 (http://nnw.fm/MY0tu) by Capgemini. Net Element itself showed a 35% revenue increase in FY2016 to $54.3 million versus the same period in 2015. SeeThruEquity (http://nnw.fm/W3Dpi) projects the company’s sales at $62.9 million in FY2017. Zacks Small Cap Research (http://nnw.fm/R3FcB) estimates Net Element’s 2017 sales at $62 million and for 2018 at $73.5 million. Net Element is a financial technology group…

FridayMay 05, 2017 2:37 pm

India Globalization Capital, Inc. (NYSE: IGC) Engages a Critical Point in Cannabis History

Cannabis is now legal medically or recreationally in 28 states in the U.S., and companies such as India Globalization Capital, Inc. (NYSE MKT: IGC) are developing revolutionary cannabinoid-based combination pharmaceutical therapies. Cannabis’ history doesn’t begin in the 1960s. Scientists have dated burned cannabis seeds found in Siberia to 3,000 B.C., and mummified psychoactive marijuana has been found in tombs of individuals buried around 2,500 B.C. Fast forward a few thousand years and add laws, regulations, and cultural stigma, and behold one of the most disputed substances. In the 1850s, recreational cannabis was considered fashionable in the U.S., and it was…

FridayMay 05, 2017 9:13 am

Kootenay Zinc Corp. (CSE: ZNK) (OTCQB: KTNNF) is “One to Watch”

Kootenay Zinc Corp. (CSE: ZNK) (OTCQB: KTNNF) is a mineral exploration and development company focused on discovering large-scale sedimentary-exhalative (“SEDEX”) zinc deposits. Based in Vancouver, British Columbia, the company is ideally positioned near its primary target, the Sully Property, located 18 miles east of the world-class Sullivan Mine. Of the 22 raw materials tracked by the Bloomberg Commodity Index, zinc was the best-performing base metal in 2016. Based on a widening global supply deficit, outlook for the commodity remains strong. As the most closely tied base metal to the Chinese economy, zinc demand and prices are expected to rise well…

ThursdayMay 04, 2017 12:27 pm

India Globalization Capital (NYSE: IGC) Strategically Staking Claims in the Medical Marijuana Markets

In a testament to its medical efficacy, 29 states and the District of Columbia have now legalized medical marijuana. This groundswell with state sanction and now widespread public acceptance has started a stampede of companies jockeying to profit from legalization. From the sale of oils and extracts to specialized cultivation, multiple companies are rushing into this new market hoping to cash in on surging demand. However, rushing in just might not be the right approach to making real money in this sector. There’s an old adage that says the way to create real wealth is to find out where everyone…

Financial news and publishing for public and private companies

Contact us: 212.418.1217